Category: Ablation Therapies

Introduction Atrial fibrillation (AFib) is the most common heart arrhythmia, affecting millions of people worldwide and posing significant risks, such as stroke, heart failure, and other cardiovascular complications. Says Dr. Ian Weisberg,  traditionally, managing AFib required patients to visit healthcare facilities for periodic check-ups, making it difficult to continuously monitor heart rhythms and ensure timely interventions. […]

 Introduction Atrial fibrillation (AFib) is a common heart rhythm disorder that affects millions of individuals worldwide, contributing to increased risk for complications such as stroke, heart failure, and diminished quality of life. Says Dr. Ian Weisberg,  while medications and medical procedures, such as catheter ablation, are essential in managing AFib, lifestyle modifications play a crucial role […]

Introduction Atrial fibrillation (AFib) is a common cardiac arrhythmia that significantly impacts the quality of life for millions of individuals worldwide. Says Dr. Ian Weisberg,  managing AFib is crucial not only to prevent debilitating symptoms but also to reduce the risk of more serious complications, such as stroke and heart failure. When it comes to treating […]

Introduction Atrial fibrillation (AF) is a prevalent cardiac arrhythmia that requires ongoing management even after interventional procedures such as catheter ablation or cardioversion.  Say’s Dr. Ian Weisberg,  traditionally, cardiac rehabilitation (CR) programs have been instrumental in helping patients recover and improve cardiovascular health post-procedure. However, conventional in-person CR programs are often limited by accessibility, time constraints, […]

Introduction Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting millions worldwide and significantly increasing the risk of stroke, heart failure, and mortality. While traditional management strategies for AF rely on standardized treatment protocols, they often fail to account for individual variations in disease progression, genetic predisposition, and patient-specific responses to therapy.  Say’s Dr. Ian […]